Copyright Reports & Markets. All rights reserved.

Global Xerophthalmia Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Xerophthalmia Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cyclosporin
      • 1.4.3 Oral Corticosteroids
      • 1.4.4 Artificial Tears
      • 1.4.5 Punctal Plugs
      • 1.4.6 Omega Supplements
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Xerophthalmia Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Eye Health Clinics
      • 1.5.4 Retail Pharmacies
      • 1.5.5 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Xerophthalmia Treatment Market Size
    • 2.2 Xerophthalmia Treatment Growth Trends by Regions
      • 2.2.1 Xerophthalmia Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Xerophthalmia Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Xerophthalmia Treatment Market Size by Manufacturers
      • 3.1.1 Global Xerophthalmia Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Xerophthalmia Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Xerophthalmia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Xerophthalmia Treatment Key Players Head office and Area Served
    • 3.3 Key Players Xerophthalmia Treatment Product/Solution/Service
    • 3.4 Date of Enter into Xerophthalmia Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Xerophthalmia Treatment Market Size by Type (2014-2019)
    • 4.2 Global Xerophthalmia Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Xerophthalmia Treatment Market Size (2014-2019)
    • 5.2 Xerophthalmia Treatment Key Players in United States
    • 5.3 United States Xerophthalmia Treatment Market Size by Type
    • 5.4 United States Xerophthalmia Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Xerophthalmia Treatment Market Size (2014-2019)
    • 6.2 Xerophthalmia Treatment Key Players in Europe
    • 6.3 Europe Xerophthalmia Treatment Market Size by Type
    • 6.4 Europe Xerophthalmia Treatment Market Size by Application

    7 China

    • 7.1 China Xerophthalmia Treatment Market Size (2014-2019)
    • 7.2 Xerophthalmia Treatment Key Players in China
    • 7.3 China Xerophthalmia Treatment Market Size by Type
    • 7.4 China Xerophthalmia Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Xerophthalmia Treatment Market Size (2014-2019)
    • 8.2 Xerophthalmia Treatment Key Players in Japan
    • 8.3 Japan Xerophthalmia Treatment Market Size by Type
    • 8.4 Japan Xerophthalmia Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Xerophthalmia Treatment Market Size (2014-2019)
    • 9.2 Xerophthalmia Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Xerophthalmia Treatment Market Size by Type
    • 9.4 Southeast Asia Xerophthalmia Treatment Market Size by Application

    10 India

    • 10.1 India Xerophthalmia Treatment Market Size (2014-2019)
    • 10.2 Xerophthalmia Treatment Key Players in India
    • 10.3 India Xerophthalmia Treatment Market Size by Type
    • 10.4 India Xerophthalmia Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Xerophthalmia Treatment Market Size (2014-2019)
    • 11.2 Xerophthalmia Treatment Key Players in Central & South America
    • 11.3 Central & South America Xerophthalmia Treatment Market Size by Type
    • 11.4 Central & South America Xerophthalmia Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Allergan Plc
      • 12.1.1 Allergan Plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Xerophthalmia Treatment Introduction
      • 12.1.4 Allergan Plc Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.1.5 Allergan Plc Recent Development
    • 12.2 Novartis AG
      • 12.2.1 Novartis AG Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Xerophthalmia Treatment Introduction
      • 12.2.4 Novartis AG Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.2.5 Novartis AG Recent Development
    • 12.3 Otsuka Pharmaceutical Co.,Ltd.
      • 12.3.1 Otsuka Pharmaceutical Co.,Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Xerophthalmia Treatment Introduction
      • 12.3.4 Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.3.5 Otsuka Pharmaceutical Co.,Ltd. Recent Development
    • 12.4 Abbott Laboratories
      • 12.4.1 Abbott Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Xerophthalmia Treatment Introduction
      • 12.4.4 Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.4.5 Abbott Laboratories Recent Development
    • 12.5 Santen Pharmaceutical Co Ltd
      • 12.5.1 Santen Pharmaceutical Co Ltd Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Xerophthalmia Treatment Introduction
      • 12.5.4 Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.5.5 Santen Pharmaceutical Co Ltd Recent Development
    • 12.6 Valent Pharmaceuticals
      • 12.6.1 Valent Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Xerophthalmia Treatment Introduction
      • 12.6.4 Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.6.5 Valent Pharmaceuticals Recent Development
    • 12.7 Akorn, Inc
      • 12.7.1 Akorn, Inc Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Xerophthalmia Treatment Introduction
      • 12.7.4 Akorn, Inc Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.7.5 Akorn, Inc Recent Development
    • 12.8 Shire Plc
      • 12.8.1 Shire Plc Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Xerophthalmia Treatment Introduction
      • 12.8.4 Shire Plc Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.8.5 Shire Plc Recent Development
    • 12.9 Thea Pharmaceuticals Limited
      • 12.9.1 Thea Pharmaceuticals Limited Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Xerophthalmia Treatment Introduction
      • 12.9.4 Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.9.5 Thea Pharmaceuticals Limited Recent Development
    • 12.10 OASIS Medical
      • 12.10.1 OASIS Medical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Xerophthalmia Treatment Introduction
      • 12.10.4 OASIS Medical Revenue in Xerophthalmia Treatment Business (2014-2019)
      • 12.10.5 OASIS Medical Recent Development
    • 12.11 Altaire Pharmaceuticals Inc
    • 12.12 Boiron USA
    • 12.13 Similasan Corporation
    • 12.14 Scope Ophthalmics Ltd.
    • 12.15 Reckitt Benckiser Group PLC
    • 12.16 Medicom Healthcare Ltd
    • 12.17 FDC Limited
    • 12.18 Lupin Limited
    • 12.19 Jamjoom Pharmaceuticals Co.
    • 12.20 Sentiss Pharma Private limited

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Xerophthalmia Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerophthalmia Treatment development in United States, Europe and China.

      The key players covered in this study
      Allergan Plc
      Novartis AG
      Otsuka Pharmaceutical Co.,Ltd.
      Abbott Laboratories
      Santen Pharmaceutical Co Ltd
      Valent Pharmaceuticals
      Akorn, Inc
      Shire Plc
      Thea Pharmaceuticals Limited
      OASIS Medical
      Altaire Pharmaceuticals Inc
      Boiron USA
      Similasan Corporation
      Scope Ophthalmics Ltd.
      Reckitt Benckiser Group PLC
      Medicom Healthcare Ltd
      FDC Limited
      Lupin Limited
      Jamjoom Pharmaceuticals Co.
      Sentiss Pharma Private limited

      Market segment by Type, the product can be split into
      Cyclosporin
      Oral Corticosteroids
      Artificial Tears
      Punctal Plugs
      Omega Supplements
      Others

      Market segment by Application, split into
      Hospital Pharmacies
      Eye Health Clinics
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Xerophthalmia Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Xerophthalmia Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now